臓器移植診断薬市場：製品、技術、用途別-2025-2030年の世界予測

臓器移植診断薬市場は、2023年に42億米ドルと評価され、2024年には44億6,000万米ドルに達すると予測され、CAGR 7.31％で成長し、2030年には68億9,000万米ドルに達すると予測されています。

臓器移植診断薬市場には、ドナーとレシピエントの適合性を評価し、移植の健康状態をモニターし、移植後の拒絶反応や感染症の可能性を検出するための診断ツールや検査の開発と応用が含まれます。これらの診断の必要性は、臓器移植を成功させ、合併症を最小限に抑え、移植片の生存期間を延ばすという重要な必要性から生じています。主な用途には、移植前適合性検査、移植後モニタリング、感染スクリーニングなどがあり、最終用途には病院、移植センター、診断検査室などが含まれます。この市場の成長要因としては、分子診断学の進歩、臓器不全につながる慢性疾患の流行、臓器移植手術の増加などが挙げられます。さらに、ゲノミクスとプロテオミクスの技術革新により、より正確で包括的な診断ソリューションが可能になり、潜在的なビジネスチャンスが広がっています。こうした機会を活用するための推奨事項としては、次世代シーケンシング技術の研究開発への投資や、非侵襲的検査法を含む診断ポートフォリオの拡大などが挙げられます。しかし、診断検査費用の高騰、低所得地域でのアクセス制限、迅速な製品承認の妨げとなる厳しい規制枠組などの制約もあります。こうした課題に対処するには、戦略的提携、コスト削減のためのイノベーション、市場浸透を高めるための有利な政策へのアドボカシーが必要です。技術革新の可能性がある分野としては、自動診断プラットフォームの開発、長期的な移植転帰を予測するためのバイオマーカー、個別化移植医療のためのAI主導型データ分析ツールなどが挙げられます。市場力学はダイナミックで競争が激しく、継続的な科学研究と技術の進歩に後押しされています。企業は、ヘルスケア機関との協力的な取り組みに注力し、アンメット・メディカル・ニーズのある新興市場に進出し、規制変更に適応する敏捷性を維持することで利益を得ることができます。これらの戦略を重視することで、利害関係者は市場での地位を高め、世界の移植診断の改善に貢献することができます。

市場力学：急速に進化する臓器移植診断薬市場の主要市場インサイトを公開

臓器移植診断薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 肝不全、腎不全、心不全の増加
  • 臓器提供を促進する政府の取り組み
  • 臓器移植診断薬を改善するための精密医療の台頭
• 市場抑制要因
  • 診断に伴う技術的限界
• 市場機会
  • 次世代の臓器移植診断薬を開発するための研究開発
  • 臓器移植における医療ツーリズムの可能性
• 市場の課題
  • 臓器移植に伴う倫理的問題

ポーターのファイブフォース：臓器移植診断薬市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：臓器移植診断薬市場における外部からの影響の把握

外部マクロ環境要因は、臓器移植診断薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析臓器移植診断薬市場における競合情勢の把握

臓器移植診断薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス臓器移植診断薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、臓器移植診断薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨臓器移植診断薬市場における成功への道筋を描く

臓器移植診断薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 肝臓、腎臓、心臓の不全の発生率の増加
    • 臓器提供を促進する政府の取り組み
    • 改善のための精密医療の台頭臓器移植診断薬
  • 抑制要因
    • 診断に関連する技術的な制限
  • 機会
    • 次世代開発のための研究開発臓器移植診断薬
    • 臓器移植における医療ツーリズムの可能性
  • 課題
    • 臓器移植に伴う倫理的問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 臓器移植診断薬市場：提供別

• 機器
• 試薬・消耗品
• ソフトウェアとサービス

第7章 臓器移植診断薬市場：技術別

• 分子技術
• 非分子技術

第8章 臓器移植診断薬市場：用途別

• 診断アプリケーション
• 調査アプリケーション

第9章 南北アメリカの臓器移植診断薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の臓器移植診断薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの臓器移植診断薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• BAG Diagnostics GmbH
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Biogenuix Medsystems Pvt. Ltd
• BioMAdvanced Diagnostics
• Biomerieux SA.
• Bruker Corporation
• CareDx Inc.
• F Hoffman La Roche Ltd.
• GenDx by Eurobio Scientific
• Genome Diagnostics B.V.
• Hologic Inc.
• Illumina Inc.
• Laboratory Corporation of America Holdings
• Luminex Corporation
• Omixon Ltd.
• Oncocyte Corporation
• Qiagen N.V.
• Quest Diagnostics Incorporated
• Randox Laboratories Ltd.
• SQI Diagnostics
• Thermo Fisher Scientific Inc.
• TransMedics, Inc.
• Werfen

LIST OF FIGURES

• FIGURE 1. ORGAN TRANSPLANT DIAGNOSTICS MARKET RESEARCH PROCESS
• FIGURE 2. ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ORGAN TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. ORGAN TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ORGAN TRANSPLANT DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ORGAN TRANSPLANT DIAGNOSTICS MARKET DYNAMICS
• TABLE 7. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY MOLECULAR TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY NON-MOLECULAR TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 28. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 29. CANADA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. CHINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 45. CHINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. CHINA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. INDIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 48. INDIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 49. INDIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 100. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. ITALY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. POLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 112. POLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 113. POLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. QATAR ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 115. QATAR ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 116. QATAR ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM ORGAN TRANSPLANT DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. ORGAN TRANSPLANT DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 145. ORGAN TRANSPLANT DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Organ Transplant Diagnostics Market was valued at USD 4.20 billion in 2023, expected to reach USD 4.46 billion in 2024, and is projected to grow at a CAGR of 7.31%, to USD 6.89 billion by 2030.

The organ transplant diagnostics market involves the development and application of diagnostic tools and tests to assess the compatibility of donors and recipients, monitor transplant health, and detect potential rejections or infections post-transplantation. The necessity for these diagnostics arises from the critical need to ensure successful organ transplantation outcomes, minimize complications, and prolong graft survival. The main application areas include pre-transplant compatibility testing, post-transplant monitoring, and infection screening, with significant end-use scope encompassing hospitals, transplant centers, and diagnostic laboratories. Influencing growth factors for this market include advancements in molecular diagnostics, increased prevalence of chronic diseases leading to organ failure, and a rise in organ transplant procedures. Additionally, technological innovations in genomics and proteomics are opening potential opportunities by enabling more precise and comprehensive diagnostic solutions. Recommendations to leverage these opportunities include investing in R&D for next-generation sequencing technologies and expanding diagnostic portfolios to include non-invasive testing methods. However, the market also faces limitations such as high costs of diagnostic tests, limited accessibility in low-income regions, and stringent regulatory frameworks that can impede swift product approvals. Addressing these challenges requires strategic collaborations, cost-reduction innovations, and advocacy for favorable policies to improve market penetration. Potential areas for innovation include the development of automated diagnostic platforms, biomarkers for predicting long-term transplant outcomes, and AI-driven data analysis tools for personalized transplant care. The nature of the organ transplant diagnostics market is dynamic and highly competitive, driven by continuous scientific research and technological advancements. Companies can benefit from focusing on collaborative efforts with healthcare institutions, expanding into emerging markets with unmet medical needs, and maintaining agility in adapting to regulatory changes. By emphasizing these strategies, stakeholders can enhance their market position and contribute to improved transplant diagnostic practices globally.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Organ Transplant Diagnostics Market

The Organ Transplant Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidences of liver, kidney, and heart failure
  • Government initiatives in promoting organ donation
  • Rise of precision medicine to improve organ transplant diagnostics
• Market Restraints
  • Technical limitations associated with diagnostics
• Market Opportunities
  • R&D to develop next generation organ transplant diagnostics
  • Potential of medical tourism in organ transplantation
• Market Challenges
  • Ethical issues associated with organ transplant

Porter's Five Forces: A Strategic Tool for Navigating the Organ Transplant Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Organ Transplant Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Organ Transplant Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Organ Transplant Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Organ Transplant Diagnostics Market

A detailed market share analysis in the Organ Transplant Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Organ Transplant Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Organ Transplant Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Organ Transplant Diagnostics Market

A strategic analysis of the Organ Transplant Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Organ Transplant Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BAG Diagnostics GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biogenuix Medsystems Pvt. Ltd, BioMAdvanced Diagnostics, Biomerieux SA., Bruker Corporation, CareDx Inc., F Hoffman La Roche Ltd., GenDx by Eurobio Scientific, Genome Diagnostics B.V., Hologic Inc., Illumina Inc., Laboratory Corporation of America Holdings, Luminex Corporation, Omixon Ltd., Oncocyte Corporation, Qiagen N.V., Quest Diagnostics Incorporated, Randox Laboratories Ltd., SQI Diagnostics, Thermo Fisher Scientific Inc., TransMedics, Inc., and Werfen.

Market Segmentation & Coverage

This research report categorizes the Organ Transplant Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Offering, market is studied across Instruments, Reagents & Consumables, and Software & Services.
• Based on Technology, market is studied across Molecular Technologies and Non-Molecular Technologies.
• Based on Application, market is studied across Diagnostic Applications and Research Applications.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of liver, kidney, and heart failure
    • 5.1.1.2. Government initiatives in promoting organ donation
    • 5.1.1.3. Rise of precision medicine to improve organ transplant diagnostics
  • 5.1.2. Restraints
    • 5.1.2.1. Technical limitations associated with diagnostics
  • 5.1.3. Opportunities
    • 5.1.3.1. R&D to develop next generation organ transplant diagnostics
    • 5.1.3.2. Potential of medical tourism in organ transplantation
  • 5.1.4. Challenges
    • 5.1.4.1. Ethical issues associated with organ transplant
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Organ Transplant Diagnostics Market, by Offering

• 6.1. Introduction
• 6.2. Instruments
• 6.3. Reagents & Consumables
• 6.4. Software & Services

7. Organ Transplant Diagnostics Market, by Technology

• 7.1. Introduction
• 7.2. Molecular Technologies
• 7.3. Non-Molecular Technologies

8. Organ Transplant Diagnostics Market, by Application

• 8.1. Introduction
• 8.2. Diagnostic Applications
• 8.3. Research Applications

9. Americas Organ Transplant Diagnostics Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Organ Transplant Diagnostics Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Organ Transplant Diagnostics Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. BAG Diagnostics GmbH
• 3. Becton, Dickinson and Company
• 4. Bio-Rad Laboratories, Inc.
• 5. Biogenuix Medsystems Pvt. Ltd
• 6. BioMAdvanced Diagnostics
• 7. Biomerieux SA.
• 8. Bruker Corporation
• 9. CareDx Inc.
• 10. F Hoffman La Roche Ltd.
• 11. GenDx by Eurobio Scientific
• 12. Genome Diagnostics B.V.
• 13. Hologic Inc.
• 14. Illumina Inc.
• 15. Laboratory Corporation of America Holdings
• 16. Luminex Corporation
• 17. Omixon Ltd.
• 18. Oncocyte Corporation
• 19. Qiagen N.V.
• 20. Quest Diagnostics Incorporated
• 21. Randox Laboratories Ltd.
• 22. SQI Diagnostics
• 23. Thermo Fisher Scientific Inc.
• 24. TransMedics, Inc.
• 25. Werfen